User:Mr. Ibrahem/Fluticasone
Clinical data | |
---|---|
Other names | Fluticasone propionate, fluticasone furoate |
AHFS/Drugs.com | Inhaled: Monograph Nose: Monograph |
Routes of administration | Intranasal, inhaled, topical |
Drug class | Glucocorticoid[1] |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 0.51% (Intranasal) |
Protein binding | 91.0% |
Metabolism | Intranasal Liver (CYP3A4-mediated) |
Elimination half-life | 10 hours |
Excretion | Eye |
Identifiers | |
| |
Chemical and physical data | |
Formula | C22H27F3O4S |
Molar mass | 444.51 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Fluticasone is a steroid which is used to treat asthma, COPD, and allergic rhinitis.[1][2] For asthma and COPD it is used for long term management.[1] It is used by breathing it into the lungs or as a nasal spray.[1][2]
Common side effects of the inhaled form include upper respiratory tract infections, throat irritation, candidiasis, cough, and headache.[1] Commons side effects of the nasal spray include a brief period of burning, nosebleeds, nausea, and sore throat.[2] It comes in two main forms fluticasone propionate and fluticasone furoate.[3]
Fluticasone propionate was patented in 1980, and approved for medical use in 1990.[4] In the United Kingdom 60 doses of 250 micrograms for breathing in costs the NHS about £25.[3] In 2018, it was the sixteenth most commonly prescribed medication in the United States, with more than 34 million prescriptions.[5][6] It is also available in combination as fluticasone/formoterol and fluticasone/salmeterol, among others.[3]
References[edit]
- ^ a b c d e f g "Fluticasone (Systemic, Oral Inhalation) Monograph for Professionals". Drugs.com. Archived from the original on 25 January 2021. Retrieved 14 December 2021.
- ^ a b c d e "Fluticasone (EENT) Monograph for Professionals". Drugs.com. Archived from the original on 24 January 2021. Retrieved 14 December 2021.
- ^ a b c BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 278. ISBN 978-0857114105.
- ^ Fischer, János; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 487. ISBN 9783527607495. Archived from the original on 2019-02-28. Retrieved 2021-12-14.
- ^ "The Top 300 of 2021". ClinCalc. Archived from the original on 12 February 2021. Retrieved 18 February 2021.
- ^ "Fluticasone - Drug Usage Statistics". ClinCalc. Archived from the original on 12 April 2020. Retrieved 18 February 2021.